Get the Stockscreener App
0.00
100.00%
-8.05
After Hours:
8.09
8.09
+
Vigil Neuroscience Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
See More
Previous Close:
$8.05
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$375.71M
Revenue:
-
Net Income/Loss:
$-82.60M
P/E Ratio:
0.00
EPS:
-2.06
Net Cash Flow:
$-48.61M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$8.10
Vigil Neuroscience Inc Stock (VIGL) Company Profile
Name
Vigil Neuroscience Inc
Sector
Industry
Phone
857-254-4445
Address
100 FORGE ROAD, WATERTOWN
Compare VIGL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VIGL
Vigil Neuroscience Inc
|
0.00 | 375.71M | 0 | -82.60M | -48.61M | -2.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vigil Neuroscience Inc Stock (VIGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Initiated | William Blair | Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-18-23 | Initiated | JMP Securities | Mkt Outperform |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Sep-16-22 | Initiated | Wedbush | Outperform |
| Aug-29-22 | Initiated | H.C. Wainwright | Buy |
| Feb-01-22 | Initiated | Guggenheim | Buy |
| Feb-01-22 | Initiated | Jefferies | Buy |
| Feb-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-01-22 | Initiated | Stifel | Buy |
View All
Vigil Neuroscience Inc Stock (VIGL) Latest News
Can Vigil Neuroscience Inc. stock weather global recessionJuly 2025 Highlights & Verified Short-Term Plans - Newser
Is Vigil Neuroscience Inc. stock a buy for dividend growthMarket Activity Summary & Expert Verified Stock Movement Alerts - Newser
Loss Report: How Vigil Neuroscience Inc. stock performs in weak economyJuly 2025 Decliners & Target Return Focused Stock Picks - moha.gov.vn
Can Vigil Neuroscience Inc. stock maintain growth trajectoryJuly 2025 Technicals & Daily Stock Momentum Reports - newser.com
Can Vigil Neuroscience Inc. stock sustain free cash flow growthProfit Target & Trade Opportunity Analysis - newser.com
How Vigil Neuroscience Inc. stock reacts to job market dataTrade Ideas & Daily Stock Momentum Reports - newser.com
Can Vigil Neuroscience Inc. stock deliver surprise earnings beatOptions Play & Weekly Chart Analysis and Guides - newser.com
Using portfolio simulators with Vigil Neuroscience Inc. included - newser.com
Can swing trading help recover from Vigil Neuroscience Inc. losses2025 Technical Overview & Smart Investment Allocation Tips - newser.com
How to interpret RSI for Vigil Neuroscience Inc. stockQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
Price action breakdown for Vigil Neuroscience Inc.Quarterly Portfolio Review & Reliable Entry Point Alerts - newser.com
Can Vigil Neuroscience Inc. stock sustain institutional interestJuly 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com
How Vigil Neuroscience Inc. stock performs during Fed tightening cyclesTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Vigil Neuroscience advances Alzheimer's drug to Phase 2 trial - MSN
How to manage a losing position in Vigil Neuroscience Inc.2025 Dividend Review & Technical Buy Zone Confirmation - newser.com
Applying Wyckoff theory to Vigil Neuroscience Inc. stock2025 Performance Recap & High Conviction Investment Ideas - newser.com
Using Bollinger Bands to evaluate Vigil Neuroscience Inc.Product Launch & High Return Trade Opportunity Guides - newser.com
Vigil Neuroscience Inc Stock (VIGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):